Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Commentary
Gespeichert in:
Veröffentlicht in: | Blood 2008, Vol.111 (3) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | |
container_title | Blood |
container_volume | 111 |
creator | MESA, Ruben A HOCHHAUS, Andreas GOLDMAN, John FISCHER, Thomas O'BRIEN, Stephen G REIFFERS, Jose J MONE, Manisha KRAHNKE, Tillmann TALPAZ, Moshe KANTARJIAN, Hagop M DRUKER, Brian SAWYERS, Charles GUILHOT, Francois SCHIFFER, Charles A CORTES, Jorge NIEDERWIESER, Dietger W GAMBACORTI, Carlo STONE, Richard M |
description | |
format | Article |
fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_20047384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20047384</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_200473843</originalsourceid><addsrcrecordid>eNqNTklOw0AQtBBImOUPfeGWQeMlC-eIiAdwjzpODx6YxeoeO5pn8REufAhHgjun2qW6KMpqWW-U1rW-LEqt9Uq1T-vqurgRede6apt6WRbfO5wi48ERuBjeVCL2YKJz8aTGAZhkdEkgTsSwgkzIMsd8DoYYhBYgI092QrcADEcQNJQynGzqwXpMNtgDeJLsMBGknhiHDDZA13MMtlNDj0J_CnwmF-0RHI0f5C0CmvkRGLRuZIJo5ulsGJrr6usTEhMmTyE9wjb6M0HOd8WVQSd0_4u3xcPu-XX7ogaUDp1hDJ2V_cDzQc77Wut23Wza5r-9H0eXdLo</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Commentary</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>MESA, Ruben A ; HOCHHAUS, Andreas ; GOLDMAN, John ; FISCHER, Thomas ; O'BRIEN, Stephen G ; REIFFERS, Jose J ; MONE, Manisha ; KRAHNKE, Tillmann ; TALPAZ, Moshe ; KANTARJIAN, Hagop M ; DRUKER, Brian ; SAWYERS, Charles ; GUILHOT, Francois ; SCHIFFER, Charles A ; CORTES, Jorge ; NIEDERWIESER, Dietger W ; GAMBACORTI, Carlo ; STONE, Richard M</creator><creatorcontrib>MESA, Ruben A ; HOCHHAUS, Andreas ; GOLDMAN, John ; FISCHER, Thomas ; O'BRIEN, Stephen G ; REIFFERS, Jose J ; MONE, Manisha ; KRAHNKE, Tillmann ; TALPAZ, Moshe ; KANTARJIAN, Hagop M ; DRUKER, Brian ; SAWYERS, Charles ; GUILHOT, Francois ; SCHIFFER, Charles A ; CORTES, Jorge ; NIEDERWIESER, Dietger W ; GAMBACORTI, Carlo ; STONE, Richard M</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><language>eng</language><publisher>Washington, DC: The Americain Society of Hematology</publisher><subject>Biological and medical sciences ; Hematologic and hematopoietic diseases ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences</subject><ispartof>Blood, 2008, Vol.111 (3)</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,4011</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20047384$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>MESA, Ruben A</creatorcontrib><creatorcontrib>HOCHHAUS, Andreas</creatorcontrib><creatorcontrib>GOLDMAN, John</creatorcontrib><creatorcontrib>FISCHER, Thomas</creatorcontrib><creatorcontrib>O'BRIEN, Stephen G</creatorcontrib><creatorcontrib>REIFFERS, Jose J</creatorcontrib><creatorcontrib>MONE, Manisha</creatorcontrib><creatorcontrib>KRAHNKE, Tillmann</creatorcontrib><creatorcontrib>TALPAZ, Moshe</creatorcontrib><creatorcontrib>KANTARJIAN, Hagop M</creatorcontrib><creatorcontrib>DRUKER, Brian</creatorcontrib><creatorcontrib>SAWYERS, Charles</creatorcontrib><creatorcontrib>GUILHOT, Francois</creatorcontrib><creatorcontrib>SCHIFFER, Charles A</creatorcontrib><creatorcontrib>CORTES, Jorge</creatorcontrib><creatorcontrib>NIEDERWIESER, Dietger W</creatorcontrib><creatorcontrib>GAMBACORTI, Carlo</creatorcontrib><creatorcontrib>STONE, Richard M</creatorcontrib><title>Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Commentary</title><title>Blood</title><subject>Biological and medical sciences</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNTklOw0AQtBBImOUPfeGWQeMlC-eIiAdwjzpODx6YxeoeO5pn8REufAhHgjun2qW6KMpqWW-U1rW-LEqt9Uq1T-vqurgRede6apt6WRbfO5wi48ERuBjeVCL2YKJz8aTGAZhkdEkgTsSwgkzIMsd8DoYYhBYgI092QrcADEcQNJQynGzqwXpMNtgDeJLsMBGknhiHDDZA13MMtlNDj0J_CnwmF-0RHI0f5C0CmvkRGLRuZIJo5ulsGJrr6usTEhMmTyE9wjb6M0HOd8WVQSd0_4u3xcPu-XX7ogaUDp1hDJ2V_cDzQc77Wut23Wza5r-9H0eXdLo</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>MESA, Ruben A</creator><creator>HOCHHAUS, Andreas</creator><creator>GOLDMAN, John</creator><creator>FISCHER, Thomas</creator><creator>O'BRIEN, Stephen G</creator><creator>REIFFERS, Jose J</creator><creator>MONE, Manisha</creator><creator>KRAHNKE, Tillmann</creator><creator>TALPAZ, Moshe</creator><creator>KANTARJIAN, Hagop M</creator><creator>DRUKER, Brian</creator><creator>SAWYERS, Charles</creator><creator>GUILHOT, Francois</creator><creator>SCHIFFER, Charles A</creator><creator>CORTES, Jorge</creator><creator>NIEDERWIESER, Dietger W</creator><creator>GAMBACORTI, Carlo</creator><creator>STONE, Richard M</creator><general>The Americain Society of Hematology</general><scope>IQODW</scope></search><sort><creationdate>2008</creationdate><title>Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Commentary</title><author>MESA, Ruben A ; HOCHHAUS, Andreas ; GOLDMAN, John ; FISCHER, Thomas ; O'BRIEN, Stephen G ; REIFFERS, Jose J ; MONE, Manisha ; KRAHNKE, Tillmann ; TALPAZ, Moshe ; KANTARJIAN, Hagop M ; DRUKER, Brian ; SAWYERS, Charles ; GUILHOT, Francois ; SCHIFFER, Charles A ; CORTES, Jorge ; NIEDERWIESER, Dietger W ; GAMBACORTI, Carlo ; STONE, Richard M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_200473843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MESA, Ruben A</creatorcontrib><creatorcontrib>HOCHHAUS, Andreas</creatorcontrib><creatorcontrib>GOLDMAN, John</creatorcontrib><creatorcontrib>FISCHER, Thomas</creatorcontrib><creatorcontrib>O'BRIEN, Stephen G</creatorcontrib><creatorcontrib>REIFFERS, Jose J</creatorcontrib><creatorcontrib>MONE, Manisha</creatorcontrib><creatorcontrib>KRAHNKE, Tillmann</creatorcontrib><creatorcontrib>TALPAZ, Moshe</creatorcontrib><creatorcontrib>KANTARJIAN, Hagop M</creatorcontrib><creatorcontrib>DRUKER, Brian</creatorcontrib><creatorcontrib>SAWYERS, Charles</creatorcontrib><creatorcontrib>GUILHOT, Francois</creatorcontrib><creatorcontrib>SCHIFFER, Charles A</creatorcontrib><creatorcontrib>CORTES, Jorge</creatorcontrib><creatorcontrib>NIEDERWIESER, Dietger W</creatorcontrib><creatorcontrib>GAMBACORTI, Carlo</creatorcontrib><creatorcontrib>STONE, Richard M</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MESA, Ruben A</au><au>HOCHHAUS, Andreas</au><au>GOLDMAN, John</au><au>FISCHER, Thomas</au><au>O'BRIEN, Stephen G</au><au>REIFFERS, Jose J</au><au>MONE, Manisha</au><au>KRAHNKE, Tillmann</au><au>TALPAZ, Moshe</au><au>KANTARJIAN, Hagop M</au><au>DRUKER, Brian</au><au>SAWYERS, Charles</au><au>GUILHOT, Francois</au><au>SCHIFFER, Charles A</au><au>CORTES, Jorge</au><au>NIEDERWIESER, Dietger W</au><au>GAMBACORTI, Carlo</au><au>STONE, Richard M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Commentary</atitle><jtitle>Blood</jtitle><date>2008</date><risdate>2008</risdate><volume>111</volume><issue>3</issue><issn>0006-4971</issn><eissn>1528-0020</eissn><cop>Washington, DC</cop><pub>The Americain Society of Hematology</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2008, Vol.111 (3) |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_pascalfrancis_primary_20047384 |
source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Biological and medical sciences Hematologic and hematopoietic diseases Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences |
title | Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Commentary |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A59%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Favorable%20long-term%20follow-up%20results%20over%206%20years%20for%20response,%20survival,%20and%20safety%20with%20imatinib%20mesylate%20therapy%20in%20chronic-phase%20chronic%20myeloid%20leukemia%20after%20failure%20of%20interferon-%CE%B1%20treatment.%20Commentary&rft.jtitle=Blood&rft.au=MESA,%20Ruben%20A&rft.date=2008&rft.volume=111&rft.issue=3&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E20047384%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |